Correlation Between Pfizer and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Roche Holding Ltd, you can compare the effects of market volatilities on Pfizer and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Roche Holding.

Diversification Opportunities for Pfizer and Roche Holding

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pfizer and Roche is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of Pfizer i.e., Pfizer and Roche Holding go up and down completely randomly.

Pair Corralation between Pfizer and Roche Holding

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Roche Holding. In addition to that, Pfizer is 1.38 times more volatile than Roche Holding Ltd. It trades about -0.13 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about -0.12 per unit of volatility. If you would invest  3,911  in Roche Holding Ltd on September 13, 2024 and sell it today you would lose (307.00) from holding Roche Holding Ltd or give up 7.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.44%
ValuesDaily Returns

Pfizer Inc  vs.  Roche Holding Ltd

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Roche Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pfizer and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Roche Holding

The main advantage of trading using opposite Pfizer and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind Pfizer Inc and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.